NASDAQ:UPC Universe Pharmaceuticals Q4 2025 Earnings Report $4.86 +0.11 (+2.32%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$4.58 -0.29 (-5.86%) As of 09/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Universe Pharmaceuticals EPS ResultsActual EPS$0.69Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AUniverse Pharmaceuticals Revenue ResultsActual Revenue$8.92 billionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUniverse Pharmaceuticals Announcement DetailsQuarterQ4 2025Date1/29/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Universe Pharmaceuticals Earnings HeadlinesUniverse Pharmaceuticals shares rise 22.6% premarket with no new catalyst identifiedSeptember 2, 2026 | msn.comUniverse Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going onSeptember 2, 2026 | msn.comMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.September 20 at 1:00 AM | Paradigm Press (Ad)Universe Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPCJuly 18, 2026 | benzinga.comUniverse Pharmaceuticals INC - Ordinary Shares - Class AJuly 17, 2026 | money.usnews.comUniverse Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | BenzingaJune 29, 2026 | benzinga.comSee More Universe Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Universe Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Universe Pharmaceuticals and other key companies, straight to your email. Email Address About Universe PharmaceuticalsUniverse Pharmaceuticals (NASDAQ:UPC). (NASDAQ: UPC) is a China-based pharmaceutical and healthcare products company. The company develops, manufactures and markets pharmaceutical products, health supplements and medical devices, with an emphasis on traditional Chinese medicine and other products used in everyday healthcare. Its product portfolio includes over-the-counter and prescription medicines designed to address a range of conditions, including respiratory, cardiovascular, digestive and dermatological ailments. Universe Pharmaceuticals also offers healthcare products and related medical devices through its distribution and sales channels. The company is headquartered in Xi’an, Shaanxi Province, China, and primarily serves the Chinese market. Universe Pharmaceuticals has operated in the pharmaceutical and healthcare sector since the late 1990s and has expanded its business through manufacturing, product development and commercial distribution activities.View Universe Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
